JnJ presenting a 66% effective rate and presenting clinical data that maybe preventing infection for the first 1-3 weeks put them as the least fraudulent manufacturer in the US market.
Nevertheless, rope.
JnJ presenting a 66% effective rate and presenting clinical data that maybe preventing infection for the first 1-3 weeks put them as the least fraudulent manufacturer in the US market.
Nevertheless, rope.
(post is archived)